Cite
Noticewala SS, Ludmir EB, Bishop AJ, et al. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. 2020;5(4):743-745doi: 10.1016/j.adro.2020.04.040.
Noticewala, S. S., Ludmir, E. B., Bishop, A. J., Chung, C., Ghia, A. J., Grosshans, D., McGovern, S., Paulino, A. C., Wang, C., Woodhouse, K. D., Yeboa, D. N., Prabhu, S. S., Weathers, S. P., Das, P., Koong, A. C., McAleer, M. F., & Li, J. (2020). Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Advances in radiation oncology, 5(4), 743-745. https://doi.org/10.1016/j.adro.2020.04.040
Noticewala, Sonal S, et al. "Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk." Advances in radiation oncology vol. 5,4 (2020): 743-745. doi: https://doi.org/10.1016/j.adro.2020.04.040
Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. 2020 May 27;5(4):743-745. doi: 10.1016/j.adro.2020.04.040. eCollection 2020. PMID: 32775785; PMCID: PMC7251361.
Copy
Download .nbib